ARROWHEAD PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Issued from Q1 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q1 2010 to Q2 2024.
  • Arrowhead Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 124M shares, a 16% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 124M +17.1M +16% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 124M +17.3M +16.2% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 108M +1.36M +1.28% Dec 31, 2023 10-Q 2024-02-06
Q3 2023 107M +1.35M +1.28% Sep 30, 2023 10-Q 2024-08-08
Q2 2023 107M +1.31M +1.24% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 107M +1.17M +1.1% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 106M +1.34M +1.28% Dec 31, 2022 10-Q 2023-02-06
Q3 2022 106M +1.63M +1.57% Sep 30, 2022 10-K 2023-11-29
Q2 2022 106M +1.59M +1.52% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 106M +1.68M +1.62% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 105M +1.6M +1.55% Dec 31, 2021 10-Q 2022-02-02
Q3 2021 104M +1.95M +1.91% Sep 30, 2021 10-K 2022-11-28
Q2 2021 104M +1.96M +1.92% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 104M +2.27M +2.23% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 103M +2.08M +2.06% Dec 31, 2020 10-Q 2021-02-04
Q3 2020 102M +6.87M +7.19% Sep 30, 2020 10-K 2021-11-22
Q2 2020 102M +7.04M +7.4% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 102M +7.08M +7.48% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 101M +8.52M +9.2% Dec 31, 2019 10-Q 2020-02-05
Q3 2019 95.5M +7M +7.91% Sep 30, 2019 10-K 2020-11-23
Q2 2019 95.2M +7.35M +8.37% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 94.7M +7.1M +8.1% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 92.6M +17.7M +23.6% Dec 31, 2018 10-Q 2019-02-07
Q3 2018 88.5M +13.7M +18.3% Sep 30, 2018 10-K 2019-11-25
Q2 2018 87.9M +13.1M +17.5% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 87.6M +12.8M +17.1% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 74.9M +505K +0.68% Dec 31, 2017 10-Q 2018-02-09
Q3 2017 74.8M +5.04M +7.23% Sep 30, 2017 10-K 2018-12-11
Q2 2017 74.8M +14.3M +23.7% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 74.8M +14.8M +24.7% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 74.4M +14.8M +24.8% Dec 31, 2016 10-Q 2017-02-06
Q3 2016 69.7M +10.2M +17.1% Sep 30, 2016 10-K 2017-12-12
Q2 2016 60.4M +931K +1.57% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 60M +525K +0.88% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 59.6M +4.91M +8.98% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 59.5M +4.89M +8.94% Sep 30, 2015 10-K 2016-12-14
Q2 2015 59.5M +6.59M +12.5% Jun 30, 2015 10-Q 2015-08-04
Q1 2015 59.4M +7.57M +14.6% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 54.7M +15.7M +40.3% Dec 31, 2014 10-Q 2015-02-09
Q3 2014 54.7M +22.2M +68.2% Sep 30, 2014 10-K 2015-12-14
Q2 2014 52.9M +21.6M +69% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 51.9M +34.8M +204% Mar 31, 2014 10-Q 2014-05-06
Q4 2013 39M +23.4M +149% Dec 31, 2013 10-Q 2014-02-04
Q3 2013 32.5M +18.9M +139% Sep 30, 2013 10-K 2014-11-25
Q2 2013 31.3M +20M +177% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 17M +6.24M +57.7% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 15.6M +5.11M +48.6% Dec 31, 2012 10-Q 2013-02-13
Q3 2012 13.6M +4.94M +57.1% Sep 30, 2012 10-K 2013-12-18
Q2 2012 11.3M -60.5M -84.3% Jun 30, 2012 10-Q 2012-08-13
Q1 2012 10.8M Mar 31, 2012 10-Q 2012-05-08
Q4 2011 10.5M Dec 31, 2011 10-Q 2012-02-09
Q3 2011 8.64M +1.47M +20.5% Sep 30, 2011 10-K 2012-12-28
Q2 2011 71.8M Jun 30, 2011 10-Q 2011-08-08
Q3 2010 7.17M Sep 30, 2010 10-K 2011-12-20
Q1 2010 12.9K* Mar 31, 2010 10-Q 2014-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.